Harbin Pharmaceutical Group Co., Ltd.

SHSE:600664 Stok Raporu

Piyasa değeri: CN¥9.9b

Harbin Pharmaceutical Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Harbin Pharmaceutical Group has a total shareholder equity of CN¥5.9B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 30.2%. Its total assets and total liabilities are CN¥14.3B and CN¥8.3B respectively. Harbin Pharmaceutical Group's EBIT is CN¥816.0M making its interest coverage ratio 146.3. It has cash and short-term investments of CN¥3.1B.

Anahtar bilgiler

30.2%

Borç/özkaynak oranı

CN¥1.80b

Borç

Faiz karşılama oranı146.3x
NakitCN¥3.13b
EşitlikCN¥5.95b
Toplam yükümlülüklerCN¥8.32b
Toplam varlıklarCN¥14.27b

Son finansal sağlık güncellemeleri

Recent updates

Harbin Pharmaceutical Group Co., Ltd. (SHSE:600664) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
Harbin Pharmaceutical Group Co., Ltd. (SHSE:600664) Looks Inexpensive But Perhaps Not Attractive Enough

Investors Aren't Buying Harbin Pharmaceutical Group Co., Ltd.'s (SHSE:600664) Earnings

Jun 25
Investors Aren't Buying Harbin Pharmaceutical Group Co., Ltd.'s (SHSE:600664) Earnings

We Think Harbin Pharmaceutical Group (SHSE:600664) Can Manage Its Debt With Ease

May 25
We Think Harbin Pharmaceutical Group (SHSE:600664) Can Manage Its Debt With Ease

Harbin Pharmaceutical Group's (SHSE:600664) Anemic Earnings Might Be Worse Than You Think

Apr 17
Harbin Pharmaceutical Group's (SHSE:600664) Anemic Earnings Might Be Worse Than You Think

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 600664's short term assets (CN¥10.7B) exceed its short term liabilities (CN¥7.9B).

Uzun Vadeli Yükümlülükler: 600664's short term assets (CN¥10.7B) exceed its long term liabilities (CN¥432.9M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 600664 has more cash than its total debt.

Borcun Azaltılması: 600664's debt to equity ratio has increased from 8.1% to 30.2% over the past 5 years.

Borç Kapsamı: 600664's debt is not well covered by operating cash flow (18%).

Faiz Kapsamı: 600664's interest payments on its debt are well covered by EBIT (146.3x coverage).


Bilanço


Sağlıklı şirketleri keşfedin